232 related articles for article (PubMed ID: 37500728)
1. Single-molecule genome-wide mutation profiles of cell-free DNA for non-invasive detection of cancer.
Bruhm DC; Mathios D; Foda ZH; Annapragada AV; Medina JE; Adleff V; Chiao EJ; Ferreira L; Cristiano S; White JR; Mazzilli SA; Billatos E; Spira A; Zaidi AH; Mueller J; Kim AK; Anagnostou V; Phallen J; Scharpf RB; Velculescu VE
Nat Genet; 2023 Aug; 55(8):1301-1310. PubMed ID: 37500728
[TBL] [Abstract][Full Text] [Related]
2. Genome-wide mutational signatures in low-coverage whole genome sequencing of cell-free DNA.
Wan JCM; Stephens D; Luo L; White JR; Stewart CM; Rousseau B; Tsui DWY; Diaz LA
Nat Commun; 2022 Aug; 13(1):4953. PubMed ID: 35999207
[TBL] [Abstract][Full Text] [Related]
3. Pan-Cancer Detection and Typing by Mining Patterns in Large Genome-Wide Cell-Free DNA Sequencing Datasets.
Che H; Jatsenko T; Lenaerts L; Dehaspe L; Vancoillie L; Brison N; Parijs I; Van Den Bogaert K; Fischerova D; Heremans R; Landolfo C; Testa AC; Vanderstichele A; Liekens L; Pomella V; Wozniak A; Dooms C; Wauters E; Hatse S; Punie K; Neven P; Wildiers H; Tejpar S; Lambrechts D; Coosemans A; Timmerman D; Vandenberghe P; Amant F; Vermeesch JR
Clin Chem; 2022 Sep; 68(9):1164-1176. PubMed ID: 35769009
[TBL] [Abstract][Full Text] [Related]
4. Genome-wide cell-free DNA fragmentation in patients with cancer.
Cristiano S; Leal A; Phallen J; Fiksel J; Adleff V; Bruhm DC; Jensen SØ; Medina JE; Hruban C; White JR; Palsgrove DN; Niknafs N; Anagnostou V; Forde P; Naidoo J; Marrone K; Brahmer J; Woodward BD; Husain H; van Rooijen KL; Ørntoft MW; Madsen AH; van de Velde CJH; Verheij M; Cats A; Punt CJA; Vink GR; van Grieken NCT; Koopman M; Fijneman RJA; Johansen JS; Nielsen HJ; Meijer GA; Andersen CL; Scharpf RB; Velculescu VE
Nature; 2019 Jun; 570(7761):385-389. PubMed ID: 31142840
[TBL] [Abstract][Full Text] [Related]
5. Resectable lung lesions malignancy assessment and cancer detection by ultra-deep sequencing of targeted gene mutations in plasma cell-free DNA.
Peng M; Xie Y; Li X; Qian Y; Tu X; Yao X; Cheng F; Xu F; Kong D; He B; Liu C; Cao F; Yang H; Yu F; Xu C; Tian G
J Med Genet; 2019 Oct; 56(10):647-653. PubMed ID: 30981987
[TBL] [Abstract][Full Text] [Related]
6. Genomic alterations of plasma cell-free DNAs in small cell lung cancer and their clinical relevance.
Du M; Thompson J; Fisher H; Zhang P; Huang CC; Wang L
Lung Cancer; 2018 Jun; 120():113-121. PubMed ID: 29748005
[TBL] [Abstract][Full Text] [Related]
7. Detection and Monitoring of Tumor-Derived Mutations in Circulating Tumor DNA Using the UltraSEEK Lung Panel on the MassARRAY System in Metastatic Non-Small Cell Lung Cancer Patients.
Leest PV; Janning M; Rifaela N; Azpurua MLA; Kropidlowski J; Loges S; Lozano N; Sartori A; Irwin D; Lamy PJ; Hiltermann TJN; Groen HJM; Pantel K; Kempen LCV; Wikman H; Schuuring E
Int J Mol Sci; 2023 Aug; 24(17):. PubMed ID: 37686200
[TBL] [Abstract][Full Text] [Related]
8. Detection and characterization of lung cancer using cell-free DNA fragmentomes.
Mathios D; Johansen JS; Cristiano S; Medina JE; Phallen J; Larsen KR; Bruhm DC; Niknafs N; Ferreira L; Adleff V; Chiao JY; Leal A; Noe M; White JR; Arun AS; Hruban C; Annapragada AV; Jensen SØ; Ørntoft MW; Madsen AH; Carvalho B; de Wit M; Carey J; Dracopoli NC; Maddala T; Fang KC; Hartman AR; Forde PM; Anagnostou V; Brahmer JR; Fijneman RJA; Nielsen HJ; Meijer GA; Andersen CL; Mellemgaard A; Bojesen SE; Scharpf RB; Velculescu VE
Nat Commun; 2021 Aug; 12(1):5060. PubMed ID: 34417454
[TBL] [Abstract][Full Text] [Related]
9. Somatic copy number alteration and fragmentation analysis in circulating tumor DNA for cancer screening and treatment monitoring in colorectal cancer patients.
Hallermayr A; Wohlfrom T; Steinke-Lange V; Benet-Pagès A; Scharf F; Heitzer E; Mansmann U; Haberl C; de Wit M; Vogelsang H; Rentsch M; Holinski-Feder E; Pickl JMA
J Hematol Oncol; 2022 Sep; 15(1):125. PubMed ID: 36056434
[TBL] [Abstract][Full Text] [Related]
10. Integrative modeling of tumor genomes and epigenomes for enhanced cancer diagnosis by cell-free DNA.
Bae M; Kim G; Lee TR; Ahn JM; Park H; Park SR; Song KB; Jun E; Oh D; Lee JW; Park YS; Song KW; Byeon JS; Kim BH; Sohn JH; Kim MH; Kim GM; Chie EK; Kang HC; Kong SY; Woo SM; Lee JE; Ryu JM; Lee J; Kim D; Ki CS; Cho EH; Choi JK
Nat Commun; 2023 Apr; 14(1):2017. PubMed ID: 37037826
[TBL] [Abstract][Full Text] [Related]
11. Sensitive detection of stage I lung adenocarcinoma using plasma cell-free DNA breakpoint motif profiling.
Guo W; Chen X; Liu R; Liang N; Ma Q; Bao H; Xu X; Wu X; Yang S; Shao Y; Tan F; Xue Q; Gao S; He J
EBioMedicine; 2022 Jul; 81():104131. PubMed ID: 35780566
[TBL] [Abstract][Full Text] [Related]
12. Multidimensional Cell-Free DNA Fragmentomic Assay for Detection of Early-Stage Lung Cancer.
Wang S; Meng F; Li M; Bao H; Chen X; Zhu M; Liu R; Xu X; Yang S; Wu X; Shao Y; Xu L; Yin R
Am J Respir Crit Care Med; 2023 May; 207(9):1203-1213. PubMed ID: 36346614
[No Abstract] [Full Text] [Related]
13. NIMBus: a negative binomial regression based Integrative Method for mutation Burden Analysis.
Zhang J; Liu J; McGillivray P; Yi C; Lochovsky L; Lee D; Gerstein M
BMC Bioinformatics; 2020 Oct; 21(1):474. PubMed ID: 33092526
[TBL] [Abstract][Full Text] [Related]
14. A pan-cancer landscape of somatic mutations in non-unique regions of the human genome.
Tarabichi M; Demeulemeester J; Verfaillie A; Flanagan AM; Van Loo P; Konopka T
Nat Biotechnol; 2021 Dec; 39(12):1589-1596. PubMed ID: 34282324
[TBL] [Abstract][Full Text] [Related]
15. Longitudinal monitoring of cell-free DNA methylation in ALK-positive non-small cell lung cancer patients.
Janke F; Angeles AK; Riediger AL; Bauer S; Reck M; Stenzinger A; Schneider MA; Muley T; Thomas M; Christopoulos P; Sültmann H
Clin Epigenetics; 2022 Dec; 14(1):163. PubMed ID: 36461127
[TBL] [Abstract][Full Text] [Related]
16. Nuclear topology modulates the mutational landscapes of cancer genomes.
Smith KS; Liu LL; Ganesan S; Michor F; De S
Nat Struct Mol Biol; 2017 Nov; 24(11):1000-1006. PubMed ID: 28967881
[TBL] [Abstract][Full Text] [Related]
17. Circulating mutational portrait of cancer: manifestation of aggressive clonal events in both early and late stages.
Yang M; Topaloglu U; Petty WJ; Pagni M; Foley KL; Grant SC; Robinson M; Bitting RL; Thomas A; Alistar AT; Desnoyers RJ; Goodman M; Albright C; Porosnicu M; Vatca M; Qasem SA; DeYoung B; Kytola V; Nykter M; Chen K; Levine EA; Staren ED; D'Agostino RB; Petro RM; Blackstock W; Powell BL; Abraham E; Pasche B; Zhang W
J Hematol Oncol; 2017 May; 10(1):100. PubMed ID: 28472989
[TBL] [Abstract][Full Text] [Related]
18. Integrated RNA and DNA sequencing improves mutation detection in low purity tumors.
Wilkerson MD; Cabanski CR; Sun W; Hoadley KA; Walter V; Mose LE; Troester MA; Hammerman PS; Parker JS; Perou CM; Hayes DN
Nucleic Acids Res; 2014 Jul; 42(13):e107. PubMed ID: 24970867
[TBL] [Abstract][Full Text] [Related]
19. Tissue and Cell-Free DNA-Based Epigenomic Approaches for Cancer Detection.
Leal A; Sidransky D; Brait M
Clin Chem; 2020 Jan; 66(1):105-116. PubMed ID: 31843869
[TBL] [Abstract][Full Text] [Related]
20. Cell-free DNA analysis in healthy individuals by next-generation sequencing: a proof of concept and technical validation study.
Alborelli I; Generali D; Jermann P; Cappelletti MR; Ferrero G; Scaggiante B; Bortul M; Zanconati F; Nicolet S; Haegele J; Bubendorf L; Aceto N; Scaltriti M; Mucci G; Quagliata L; Novelli G
Cell Death Dis; 2019 Jul; 10(7):534. PubMed ID: 31296838
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
